49502-420 : Eldepryl 5 mg Oral Capsule
NDC: | 49502-420 |
Labeler: | Mylan Specialty |
Product Type: | Human Prescription Drug |
Drug Name: | Eldepryl |
Dosage Form: | Oral Capsule |
Application #: | NDA020647 |
Rev. Date: |
Appearance:
Markings: | Somerset;logo;Eldepryl;5;mg |
Shapes: |
Capsule |
Colors: |
Blue |
Size (mm): | 16 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 49502-420-60: 60 CAPSULE IN 1 BOTTLE (49502‑420‑60)
Active Ingredients:
- Selegiline Hydrochloride
Dosage Strength:
- 5 mg
Inactive Ingredients:
- Anhydrous Citric Acid
- Lactose
- Magnesium Stearate
- Cellulose, Microcrystalline
Pharmaceutical Classes:
- Monoamine Oxidase Inhibitor [EPC]
- Monoamine Oxidase Inhibitors [MoA]
- Monoamine Oxidase Type B Inhibitor [EPC]
- Monoamine Oxidase-B Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 39506-011 Eldepryl 5 mg Oral Tablet by Somerset Pharmaceuticals Inc.
- 39506-022 Eldepryl 5 mg Oral Capsule by Somerset Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 49502-418Next: 49502-425 >
Related Discussions:
selegiline hydrochloride
5 mg capsules ## Selegiline hydrochloride is known as an MAO inhibitor used to treat Parkinson's like or Parkinson... 1 reply
5 mg capsules ## Selegiline hydrochloride is known as an MAO inhibitor used to treat Parkinson's like or Parkinson... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.